Nutrients · 2026
Nutritional and Metabolic Trajectories up to 10 Years After Metabolic and Bariatric Surgery: A Tertiary-Centre Retrospective Longitudinal Cohort Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mitchell Sebastian, Bhandari Priyanka, Houston Margaret, Wardani Titisari, Suhaimi Nur Balzureen, Willcock Treeve, Joyce Brian, Drummond Gillian, Wallace Beverly, Mair Kellyanne, Whelan Frieda, Clyde Danielle, Ewing Anne, Lamb Peter J, Robertson Andrew G
Аннотация
BACKGROUND/OBJECTIVES: Metabolic and bariatric surgery (MBS) is the most effective durable treatment for severe obesity but predisposes to micronutrient deficiency. Long-term, broad-panel biochemical data are scarce. We examined nutritional and metabolic trajectories over up to 10 years and compared sleeve gastrectomy (SG) with Roux-en-Y gastric bypass (RYGB).
METHODS: Retrospective single-centre cohort undergoing MBS (NHS Lothian, 2011-2025). Twenty-five biochemical markers were captured at baseline, 6 months, 1, 5 and 10 years, and analysed using linear mixed-effects models adjusted for procedure, sex, age, baseline BMI, diabetes and deprivation, with Benjamini-Hochberg correction.
RESULTS: Of 458 patients, 426 were analysed (82.4% female; median age 49 years; median baseline BMI 44.2 kg/m2; SG 55.2%, RYGB 41.1%; median follow-up 7.0 years). Median total and excess weight loss were 21.6% and 49.2%. Pre-operative type 2 diabetes affected 99/422 (23.5%), resolving in 41 (41.4%). Adjusted calcium fell (p < 0.001) and parathyroid hormone (PTH) rose (+0.22 pmol/L/year [95% CI 0.11, 0.33], p < 0.001) despite vitamin D increasing (+1.20 nmol/L/year, p < 0.001); elevated PTH persisted in ~33%. Haemoglobin declined (-0.32 g/L/year, p = 0.026), below-range values rising from 26.3% (109/415) to 38.5% (84/218). Serum iron and transferrin saturation rose (p = 0.034; p = 0.002). B-vitamins increased (all p < 0.001) except thiamine. Selenium, red-cell selenium and zinc fell (all p < 0.05); albumin declined (p < 0.001); cholesterol was stable. Folate and vitamin E trajectories differed between SG and RYGB; other markers did not. The PTH rise was steeper with proton pump inhibitor use (p = 0.002) and baseline BMI ≥ 50 kg/m2 (p = 0.003).
CONCLUSIONS: Within a structured service with high supplement compliance, frank deficiency was uncommon for most markers. Nonetheless, progressive biochemical changes emerged and persisted, most consistently falling calcium with rising PTH and declining haemoglobin. These findings support indefinite, systematic nutritional surveillance after MBS.
METHODS: Retrospective single-centre cohort undergoing MBS (NHS Lothian, 2011-2025). Twenty-five biochemical markers were captured at baseline, 6 months, 1, 5 and 10 years, and analysed using linear mixed-effects models adjusted for procedure, sex, age, baseline BMI, diabetes and deprivation, with Benjamini-Hochberg correction.
RESULTS: Of 458 patients, 426 were analysed (82.4% female; median age 49 years; median baseline BMI 44.2 kg/m2; SG 55.2%, RYGB 41.1%; median follow-up 7.0 years). Median total and excess weight loss were 21.6% and 49.2%. Pre-operative type 2 diabetes affected 99/422 (23.5%), resolving in 41 (41.4%). Adjusted calcium fell (p < 0.001) and parathyroid hormone (PTH) rose (+0.22 pmol/L/year [95% CI 0.11, 0.33], p < 0.001) despite vitamin D increasing (+1.20 nmol/L/year, p < 0.001); elevated PTH persisted in ~33%. Haemoglobin declined (-0.32 g/L/year, p = 0.026), below-range values rising from 26.3% (109/415) to 38.5% (84/218). Serum iron and transferrin saturation rose (p = 0.034; p = 0.002). B-vitamins increased (all p < 0.001) except thiamine. Selenium, red-cell selenium and zinc fell (all p < 0.05); albumin declined (p < 0.001); cholesterol was stable. Folate and vitamin E trajectories differed between SG and RYGB; other markers did not. The PTH rise was steeper with proton pump inhibitor use (p = 0.002) and baseline BMI ≥ 50 kg/m2 (p = 0.003).
CONCLUSIONS: Within a structured service with high supplement compliance, frank deficiency was uncommon for most markers. Nonetheless, progressive biochemical changes emerged and persisted, most consistently falling calcium with rising PTH and declining haemoglobin. These findings support indefinite, systematic nutritional surveillance after MBS.